References
1. Pecorino B, Lagana AS, Chiantera V, Ferrara M, Di Stefano AB, Di
Donna MC, et al. Progression Free Survival, Overall Survival, and
Relapse Rate in Endometrioid Ovarian Cancer and Synchronous
Endometrial-Ovarian Endometrioid Cancer (SEO-EC): Results from a Large
Retrospective Analysis. Medicina (Kaunas). 2022;58(12).
2. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival
Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma
During the Platinum Era: A Meta-Analysis. J Clin Oncol.
2023;41(25):4065-76.
3. Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N,
Sessa C, et al. Newly diagnosed and relapsed epithelial ovarian
carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment
and follow-up. Ann Oncol. 2018;29(Suppl 4):iv259.
4. Leitao MM, Jr., Chi DS. Surgical management of recurrent ovarian
cancer. Semin Oncol. 2009;36(2):106-11.
5. Fortner RT, Trewin-Nybraten CB, Paulsen T, Langseth H.
Characterization of ovarian cancer survival by histotype and stage: A
nationwide study in Norway. Int J Cancer. 2023;153(5):969-78.
6. Bouchard-Fortier G, Panzarella T, Rosen B, Chapman W, Gien LT.
Endometrioid Carcinoma of the Ovary: Outcomes Compared to Serous
Carcinoma After 10 Years of Follow-Up. J Obstet Gynaecol Can.
2017;39(1):34-41.
7. Li S, Zhu Z. Chemotherapy is not necessary for early-stage serous and
endometrioid ovarian cancer after undergoing comprehensive staging
surgery. J Ovarian Res. 2020;13(1):91.
8. Maeda D, Shih Ie M. Pathogenesis and the role of ARID1A mutation in
endometriosis-related ovarian neoplasms. Adv Anat Pathol.
2013;20(1):45-52.
9. Ayhan A, Mao TL, Seckin T, Wu CH, Guan B, Ogawa H, et al. Loss of
ARID1A expression is an early molecular event in tumor progression from
ovarian endometriotic cyst to clear cell and endometrioid carcinoma. Int
J Gynecol Cancer. 2012;22(8):1310-5.
10. Makris GM, Manousopoulou G, Battista MJ, Salloum I, Chrelias G,
Chrelias C. Synchronous Endometrial and Ovarian Carcinoma: A Case
Series. Case Rep Oncol. 2017;10(2):732-6.
11. Singh N. Synchronous tumours of the female genital tract.
Histopathology. 2010;56(3):277-85.
12. Le Thanh V, Bell R, Symons N, Soleymani Majd H. The role of
multidisciplinary team and stepwise pelvic devascularization to minimize
blood loss during total pelvic exenteration for patients refusing blood
transfusion. Clin Case Rep. 2023;11(9):e7689.
13. Anglesio MS, Wang YK, Maassen M, Horlings HM, Bashashati A, Senz J,
et al. Synchronous Endometrial and Ovarian Carcinomas: Evidence of
Clonality. J Natl Cancer Inst. 2016;108(6):djv428.
14. Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D,
Kehoe S, et al. FIGO staging of endometrial cancer: 2023. Int J Gynaecol
Obstet. 2023;162(2):383-94.
15. Swift BE, Covens A, Mintsopoulos V, Parra-Herran C, Bernardini MQ,
Nofech-Mozes S, et al. The effect of complete surgical staging and
adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid
ovarian carcinoma. Int J Gynecol Cancer. 2022;32(4):525-31.
16. Blank.
17. Addley S, Alazzam M, Johnson C, Soleymani Majd H. Rectovaginal
extragastrointestinal stromal tumour (EGIST): an additional entity to be
considered in the differential diagnosis of tumours of the rectovaginal
septum. BMJ Case Rep. 2021;14(3).
18. Soleymani Majd H, Collins SL, Addley S, Weeks E, Chakravarti S,
Halder S, et al. The modified radical peripartum cesarean hysterectomy
(Soleymani-Alazzam-Collins technique): a systematic, safe procedure for
the management of severe placenta accreta spectrum. Am J Obstet Gynecol.
2021;225(2):175 e1- e10.
19. Cowdell I, Smyth SL, Eltawab S, Soleymani Majd H. Radical
abdomino-pelvic surgery in the management of uterine carcinosarcoma with
concomitant para-aortic lymphadenopathy metastasising from anal
carcinoma. BMJ Case Rep. 2022;15(11).
20. Khan M, Eltawab S, Gietzmann W, Soleymani Majd H. Laterally extended
endopelvic resection as part of the surgical management of disseminated
retroperitoneal leiomyomatosis mimicking low-grade sarcoma in a patient
with a solitary kidney. BMJ Case Rep. 2023;16(6).
21. Cowie P, Eastwood B, Smyth S, Soleymani Majd H. Atypical
presentation of intravascular leiomyomatosis mimicking advanced uterine
sarcoma: modified laterally extended endopelvic resection with
preservation of pelvic neural structures. BMJ Case Rep. 2021;14(9).
22. Guerrisi R, Smyth SL, Ismail L, Horne A, Ferrari F, Soleymani Majd
H. Approach to Radical Hysterectomy for Cervical Cancer in Pregnancy:
Surgical Pathway and Ethical Considerations. J Clin Med. 2022;11(24).
23. Smyth SL, Siddiqi A, Athanasou N, Whitwell D, Soleymani Majd H.
Adamantinoma: A review of the current literature. J Bone Oncol.
2023;41:100489.
24. Smyth S, Addley S, Alazzam M, Soleymani Majd H. Adamantinoma:
metastatic disease masquerading as a gynaecological malignancy. BMJ Case
Rep. 2021;14(6).
25. Tozzi R, Hardern K, Gubbala K, Garruto Campanile R, Soleymani Majd
H. En-bloc resection of the pelvis (EnBRP) in patients with stage
IIIC-IV ovarian cancer: A 10 steps standardised technique. Surgical and
survival outcomes of primary vs. interval surgery. Gynecol Oncol.
2017;144(3):564-70.